Table 1.
Full Cohort (% Unless Otherwise Specified) |
White |
Minority |
||
---|---|---|---|---|
Parent Characteristics | N = 95 | N = 55 | N = 40 | P |
Parent gender | 0.42 | |||
Female | 81 | 84 | 77 | |
Male | 19 | 16 | 23 | |
Parent education | 0.65 | |||
Higher than high school graduate | 82 | 84 | 80 | |
High school graduate or lesser | 18 | 16 | 20 | |
Parent race/ethnicity | N/A | |||
White | 58 | 100 | 0 | |
Black | 8 | 0 | 20 | |
Hispanic | 23 | 0 | 55 | |
Other | 11 | 0 | 25 | |
Study site | 0.09 | |||
Boston Children’s Hospital/Dana-Farber Cancer Institute | 22 | 25 | 18 | |
Children’s Hospital Los Angeles | 18 | 16 | 20 | |
Children’s Hospital of Philadelphia | 20 | 24 | 15 | |
Columbia University Medical Center | 3 | 2 | 5 | |
Cook Children’s | 7 | 5 | 10 | |
Seattle Children’s Research Institute | 6 | 7 | 5 | |
St Jude Children’s Research Center | 6 | 7 | 5 | |
Stanford/Packard Children’s Hospital | 9 | 2 | 20 | |
University of Chicago | 7 | 11 | 3 | |
Religious coping | ||||
Greater use of religious coping | 49 | 35 | 68 | 0.002 |
Lesser use of religious coping | 51 | 65 | 33 | |
Child Characteristics | ||||
Child gender | 0.67 | |||
Female | 40 | 42 | 38 | |
Male | 60 | 58 | 63 | |
Child age at time of parent enrollment (yrs) | Mean 6.4; median 6 (SD 3.1) | Mean 6.7; median 7 (SD 2.7) | Mean 6.1; median 5 (SD 3.6) | 0.35 |
Care and Treatment Characteristics | 0.02 | |||
Neuroblastoma status | ||||
Recurrent | 77 | 85 | 65 | |
Refractory to initial therapy | 23 | 15 | 35 | |
Number of prior chemotherapeutic regimens | Mean 3.5; median 3 (SD 2.2) | Mean 3.6; median 4 (SD 2.5) | Mean 3.3; median 3 (SD 1.8) | 0.37 |
N/A = not available.
P-values indicate Chi-squared tests comparing proportions who are white (white non-Hispanic) Vs. minority (nonwhite or Hispanic); t-tests were used for continuous variables.